22ND CENTURY GROUP

22nd-century-group-logo

22nd Century Group is a plant biotechnology company developing tobacco harm reduction and smoking cessation products. In 1998, Joseph Pandolfino founded 22nd Century Limited, LLC (22nd Century) to provide funding to North Carolina State University (NCSU) for research and development collaboration on nicotine biosynthesis in the tobacco plant. Mr. Pandolfino questioned, coffee without caffeine and beer without alcohol is commercially available so why arenโ€™t tobacco cigarettes without nicotine ... a choice for consumers? Further, he hypothesized: If it were possible to produce tobacco cigarettes without nicotine, smokers could use these extraordinary cigarettes to successfully quit smoking. A paradox to be sure. Nonetheless, Mr. Pandolfinoโ€™s hypothesis stemmed from his careful observation of real smokers. As an importer of tobacco-free herbal cigarettes, Mr. Pandolfino had come to realize that some consumers were using nicotine-free herbal cigarettes to successfully quit smoking. Anecdotal evidence suggested that this approach was actually effective. The biggest problem with the novel โ€œtherapyโ€ was the fact that herbal cigarettes have distinct taste and aroma characteristics which greatly limit their consumer appeal and acceptance. Indeed, although various processes were developed to improve these nicotine-free herbal cigarettes, it became clear that their peculiar taste and aroma characteristics would never appeal to mainstream smokers. If, on the other hand, a tobacco cigarette without nicotine could be developed, Mr. Pandolfino believed a new cigarette category could prove an attractive product choice to all smokers. With this in mind, Mr. Pandolfino set out to investigate the feasibility of efficiently producing tobacco cigarettes without nicotine.

#SimilarOrganizations #People #Financial #Website #More

22ND CENTURY GROUP

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
1998-01-01

Address:
Clarence, New York, United States

Country:
United States

Website Url:
http://www.xxiicentury.com

Total Employee:
11+

Status:
Active

Contact:
716-270-1523

Email Addresses:
[email protected]

Total Funding:
111.74 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

stemline-therapeutics-logo

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.


Current Advisors List

not_available_image

James L. Myracle Technical Advisor @ 22nd Century Group
Advisor

Current Employees Featured

henry-sicignano_image

Henry Sicignano
Henry Sicignano President & Secretary @ 22nd Century Group
President & Secretary
2010-04-01

not_available_image

Michael J. Dalton
Michael J. Dalton Owner @ 22nd Century Group
Owner

james-a-mish_image

James A. Mish
James A. Mish Chief Executive Officer @ 22nd Century Group
Chief Executive Officer

not_available_image

James C. Morrison
James C. Morrison Regulatory Affairs Consultant @ 22nd Century Group
Regulatory Affairs Consultant

john-t-brodfuehrer_image

John T. Brodfuehrer
John T. Brodfuehrer Chief Financial Officer @ 22nd Century Group
Chief Financial Officer

joseph-alexander-dunn_image

Joseph Alexander Dunn
Joseph Alexander Dunn Director @ 22nd Century Group
Director

michael-moynihan_image

Michael Moynihan
Michael Moynihan Vice President of R&D @ 22nd Century Group
Vice President of R&D

not_available_image

James W. Cornell
James W. Cornell Director @ 22nd Century Group
Director

michael-zercher_image

Michael Zercher
Michael Zercher President & Chief Operating Officer @ 22nd Century Group
President & Chief Operating Officer
2019-12-01

Founder


joseph-pandolfino_image

Joseph Pandolfino

Stock Details


Company's stock symbol is NYSEMKT:XXII

Acquisitions List

Date Company Article Price
2022-05-13 GVB Biopharma GVB Biopharma acquired by 22nd Century Group 55 M USD

Investors List

crede-cg-iii-ltd_image

Crede CG III LTD

Crede CG III LTD investment in Post-IPO Equity - 22nd Century Group

Official Site Inspections

http://www.xxiicentury.com Semrush global rank: 1.37 M Semrush visits lastest month: 21.03 K

  • Host name: 109.150.40.45.host.secureserver.net
  • IP address: 45.40.150.109
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "22nd Century Group" on Search Engine